• home
  • Testimony: Massachusetts Fiduciary Rule Public Hearing -  Proposed Amendments To 950 CMR 12.200

Testimony

January 7, 2020

Massachusetts Fiduciary Rule Public Hearing -  Proposed Amendments To 950 CMR 12.200

ACLI Testimony on 01/07/20 by Paul A. Quaranto, Chairman, Chief Executive Officer and President, Boston Mutual and Susan Neely, President and CEO, ACLI on proposed amendments to 940 CMR 12.200.

Read the full testimony. (PDF)

Date Posted: January 7, 2020
Document ID: CT20-056
Contact: Jessica Mancari, 202-624-2338

FEATURED

2022 REFOCUS
CONFERENCE

REFocus2022_tile ReFocus Conference 2022 Join ACLI and SOA on March 6-9, Las Vegas, NV!

Economic
Empowerment

EERE_promoCube2 ACLI EERE Initiative: ACLI launched its Economic Empowerment & Racial Equity Initiative on October 12, 2020.

Quick Links

PROTECTING
EVERY FUTURE

PEF_tile Protecting Every Future is a network of diverse voices and people. Share your story with us!

COVID-19
UPDATES

2020_COVID19Updates_PCQL COVID-19 Updates Industry response to COVID-19, updates from ACLI on the coronavirus pandemic.

RETIREMENT
SECURITY

$name Retirement Security We are committed to helping people live and retire with financial peace of mind.

BEST
INTEREST

$name Regulation Best Interest We seek solutions that promote and protect the best interest of Americans.

ACLI
IMPACT

2019_IMPACT_PCQL IMPACT Read and subscribe to our insights on trends and topics that impact Americans' financial security.

LIFE INSURERS
FACT BOOK

factbook2021_thumbnail Life Insurers Fact Book 2021 The ACLI Life Insurers Fact Book is celebrating 75 years of serving the life insurance industry!

MISSING
POLICY TIPS

$name Missing Policy Tips Suspect your loved one owned a life insurance policy These tips can help with your search.

Economic
Empowerment

EERE_promoCube2 ACLI EERE Initiative: ACLI launched its Economic Empowerment & Racial Equity Initiative on October 12, 2020.

#MEETING
THE MOMENT

2020_MeetingtheMoment_PCQL #MeetingTheMoment Life Insurers are #MeetingTheMoment in response to COVID-19.